Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ocular Surface Conditions in Asian Glaucoma Patients With Existing Corneal Disorders Switching From Preserved Prostaglandin Analogues Monotherapy to Preservative-free Tafluprost

NCT04654611 is registered in ClinicalTrials.gov with Tun Hussein Onn National Eye Hospital as lead sponsor.

NCT NCT04654611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04654611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ocular Surface Conditions in Asian Glaucoma Patients With Existing Corneal Disorders Switching From Preserved Prostaglandin Analogues Monotherapy to Preservative-free Tafluprost
Lead sponsor
Tun Hussein Onn National Eye Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2019
Completion date
February 1, 2020
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, ocular hypertension, primary open angle glaucoma